Diabetes Duration, Cholesterol Levels, and Risk of Cardiovascular Diseases in Individuals With Type 2 Diabetes
- PMID: 38366387
- PMCID: PMC11570539
- DOI: 10.1210/clinem/dgae092
Diabetes Duration, Cholesterol Levels, and Risk of Cardiovascular Diseases in Individuals With Type 2 Diabetes
Abstract
Objective: To investigate the association of diabetes duration with cardiovascular disease (CVD) risk and to examine the relationship between lipid levels and CVD risk over the duration.
Methods: Using the Korean National Health Insurance Service Cohort database, we identified 2 359 243 subjects with type 2 diabetes aged ≥ 20 years in 2015 to 2016. Baseline lipid levels and diabetes duration were evaluated and followed up until December 2020 (mean follow-up, 3.9 years). Subjects were categorized according to diabetes duration (new-onset, < 5 years, 5-9 years, or ≥ 10 years). We analyzed the new-onset diabetes group with low-density lipoprotein cholesterol (LDL-C) < 70 mg/dL as the reference group. The hazard ratios (HRs) and 95% CIs of myocardial infarction (MI) and ischemic stroke (IS) were estimated using a Cox proportional hazards model adjusted for potential confounders.
Results: During follow-up, 45 883 cases of MI and 53 538 cases of IS were identified. The risk of MI or IS began to increase at LDL-C ≥ 160 mg/dL in the new-onset diabetes group, and at LDL-C ≥ 130 mg/dL in the group with diabetes duration < 5 years. Among subjects with diabetes duration of 5 to 9 years, LDL-C levels of 100-129 mg/dL, 130-159 mg/dL, and ≥ 160 mg/dL were significantly associated with the risk of MI (HR [95% CI] 1.13 [1.04-1.22], 1.28 [1.17-1.39], and 1.58 [1.42-1.76], respectively). MI risk in the diabetes duration ≥ 10 years group was increased by 16%, even in the LDL-C 70-99 mg/dL population (HR [95% CI] 1.16 [1.08-1.25]).
Conclusion: This population-based longitudinal study revealed that the LDL-C cutoff level for increasing the risk of CVD varied with diabetes duration and that the target LDL-C level should depend on the duration.
Keywords: Korea; cardiovascular disease; cholesterol; diabetes mellitus; duration.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.
Figures

Comment in
-
Diabetes Duration and the Reverse Impact Between Cholesterol Levels and Risk Among Individuals With Type 2 Diabetes.J Clin Endocrinol Metab. 2024 Nov 18;109(12):e2352-e2354. doi: 10.1210/clinem/dgae217. J Clin Endocrinol Metab. 2024. PMID: 38569006 No abstract available.
Similar articles
-
Risk of Cardiovascular Disease according to Baseline Low-Density Lipoprotein Cholesterol Level in Different Age Groups in Korean Diabetes Population: A Cohort Study.Diabetes Metab J. 2024 Mar;48(2):265-278. doi: 10.4093/dmj.2022.0443. Epub 2024 Feb 26. Diabetes Metab J. 2024. PMID: 38403889 Free PMC article.
-
Cholesterol levels and development of cardiovascular disease in Koreans with type 2 diabetes mellitus and without pre-existing cardiovascular disease.Cardiovasc Diabetol. 2019 Oct 22;18(1):139. doi: 10.1186/s12933-019-0943-9. Cardiovasc Diabetol. 2019. PMID: 31640795 Free PMC article.
-
Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus.Diabetes Metab J. 2023 Jan;47(1):45-58. doi: 10.4093/dmj.2021.0344. Epub 2023 Jan 26. Diabetes Metab J. 2023. PMID: 36727163 Free PMC article.
-
Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.Hum Reprod Update. 2020 Nov 1;26(6):942-960. doi: 10.1093/humupd/dmaa029. Hum Reprod Update. 2020. PMID: 32995872 Free PMC article.
-
Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement.Diabetes Metab J. 2023 Jan;47(1):1-9. doi: 10.4093/dmj.2022.0448. Epub 2023 Jan 20. Diabetes Metab J. 2023. PMID: 36727160 Free PMC article. Review.
Cited by
-
Circulating MicroRNA-1 for the early prediction of unstable angina and the value of second coronary angiography in type 2 diabetes patients with chest pain and no ST-T changes on electrocardiograms.BMC Cardiovasc Disord. 2025 May 28;25(1):411. doi: 10.1186/s12872-025-04880-9. BMC Cardiovasc Disord. 2025. PMID: 40437361 Free PMC article.
-
Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian Associations of Medical Diabetologists database.Cardiovasc Diabetol. 2025 Feb 28;24(1):94. doi: 10.1186/s12933-025-02648-1. Cardiovasc Diabetol. 2025. PMID: 40022078 Free PMC article.
-
Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function.J Lipid Atheroscler. 2025 May;14(2):190-199. doi: 10.12997/jla.2025.14.2.190. Epub 2025 Apr 9. J Lipid Atheroscler. 2025. PMID: 40492185 Free PMC article.
-
Joint association of the newly proposed dietary index for gut microbiota and sleep disorders with survival among US adult population with diabetes and pre-diabetes.Nutr J. 2025 Jun 18;24(1):95. doi: 10.1186/s12937-025-01162-0. Nutr J. 2025. PMID: 40533747 Free PMC article.
References
-
- Arnett DK, Blumenthal RS, Albert MA, et al. . 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation. 2019;140(11):e563‐e595. - PMC - PubMed
-
- Cosentino F, Grant PJ, Aboyans V, et al. . 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255‐323. - PubMed
-
- de Jong M, Woodward M, Peters SAE. Duration of diabetes and the risk of major cardiovascular events in women and men: a prospective cohort study of UK Biobank participants. Diabetes Res Clin Pract. 2022;188:109899. - PubMed
-
- Fox CS, Sullivan L, D'Agostino RB Sr, Wilson PW, Framingham Heart Study . The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care. 2004;27(3):704‐708. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical